Testing and clinical implications for non‐V600 <i>BRAF</i> mutations in metastatic <i>NRAS</i> <sup> <i>mt</i> </sup> melanoma
Georg Richtig(Medical University of Graz), Ariane Aigelsreiter(Medical University of Graz), Martin Pichler(University of Augsburg), Erika Richtig(Medical University of Graz), Karl Kashofer(Medical University of Graz), Martin Grübler(University of Bern), Barbara Ehall(Medical University of Graz), Gerald Höefler(Medical University of Graz), Gerlinde Winter(Medical University of Graz), Lukas Koch(Medical University of Graz), Ákos Heinemann(Medical University of Graz)
Cited by 3
Related Papers
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
|Cancer and Metastasis Reviews|2020|334
A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode
|Bipolar Disorders|2018|246